The Effects of Using Virtual Reality Glasses During the Non-Stress Test

Inonu University

Status

Completed

Conditions

Pregnancy Related

Treatments

Other: Virtual Reality (VR) glasses

Study type

Interventional

Funder types

Other

Identifiers

NCT05711875

2021/2302

Details and patient eligibility

About

The aim of this study to determine the effect of virtual reality glasses use on anxiety, stress and fetal well-being during the non-stress test. Personal information form was used as data collection form, Revised Prenatal Distress Questionnaire (NUPDQ-17 Item Version) was used to assess distress, State-Trait Anxiety Inventory (STAI) was used to assessanxiety.

Full description

Material and Method

This research was conducted between between October 2021 and February 2022 in Fethi Sekin City Hospital. When power analysis was performed, the sample size was calculated to be at least 71 women for each group (71 experiments, 71 controls). During the NST procedures, VR glasses were given to the participants in the experimental group by the researcher for the intervention. Data collection form for experimental and control groups before the NST procedures; Revised Prenatal Distress Questionnaire (NUPDQ-17 Item Version) and State-Trait Anxiety Inventory (STAI) were applied two times before and after NST procedure. After the NST procedures, both groups were re-administered. Descriptive statistics and independent t-test were used for data analysis.

Enrollment

71 patients

Sex

Female

Ages

15 to 49 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

not carrying any risk factors (e.g., preeclampsia, intrauterine growth retardation (IUGR), premature rupture of membranes, gestational diabetes)
having a singleton pregnancy and no vision problems
No uterine contraction on the tracing paper at the end of NST
having eaten at least two hours before NST
not smoking or drinking alcoholic beverages at least two hours before NST
having a systolic blood pressure value in the range of 90-140 mmHg and a diastolic blood pressure value in the range of 60-90 mm/Hg
not having any problems related to the health of the fetus (such as fetal anomaly, intrauterine growth retardation)
having no communication barriers.

Exclusion criteria